Helixmith initiates Phase 2 trial of Engensis in treatment of Lou Gehrig`s disease in US
The investigational drug is a plasmid-based gene therapy to deliver the hepatocyte growth factor (HGF) directly to patient cells, capable of ... http://dlvr.it/RlxJgd
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.